Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is a fast-growing cancer of the blood and bone marrow. It starts when the body makes too many immature white blood cells, called lymphoblasts, in the bone marrow. These abnormal cells quickly crowd out healthy blood cells, leading to various symptoms and requiring prompt treatment.

What is Acute Lymphoblastic Leukemia?

Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow, the soft tissue inside your bones where blood cells are made. It's called "acute" because it develops quickly, and "lymphoblastic" because it involves a specific type of immature white blood cell called a lymphoblast.

Your bone marrow normally produces three main types of blood cells: red blood cells (which carry oxygen), white blood cells (which fight infection), and platelets (which help blood clot). In ALL, the body produces too many abnormal, immature white blood cells called lymphoblasts. These lymphoblasts do not mature properly and cannot fight infection effectively. These abnormal cells multiply rapidly and crowd out the healthy blood cells in the bone marrow. This means your body can't make enough healthy red blood cells, white blood cells, or platelets. This shortage of normal blood cells leads to many of the symptoms of ALL. ALL is the most common type of cancer in children, but it can also affect adults.

Symptoms

Symptoms of acute lymphoblastic leukemia (ALL) often appear suddenly and can include feeling very tired, frequent infections, easy bruising or bleeding, and bone or joint pain. These signs happen because the abnormal leukemia cells crowd out healthy blood cells, preventing them from doing their jobs properly.

The symptoms of ALL are usually caused by a shortage of healthy blood cells. Due to low red blood cells (anemia): You might feel very tired and weak, look pale, or feel short of breath, even with light activity. Red blood cells carry oxygen, and a low count means less oxygen gets to your body's tissues. Due to low healthy white blood cells: You may get frequent infections, fevers, or have infections that are hard to get rid of. Healthy white blood cells are crucial for fighting off germs. Due to low platelets: You might notice easy bruising, nosebleeds, bleeding gums, or tiny red spots on your skin (petechiae). Platelets are essential for blood clotting. Other common symptoms can include pain in your bones or joints, swollen lymph nodes (small, bean-shaped glands that are part of your immune system) in your neck, armpit, or groin, and a swollen abdomen due to an enlarged liver or spleen. Some people may also experience unexplained weight loss or loss of appetite.

Causes & risk factors

The exact cause of acute lymphoblastic leukemia (ALL) is often unknown, but it involves genetic changes (mutations) in the DNA of bone marrow cells. While not directly inherited, certain factors can increase your risk, such as previous cancer treatments or specific genetic syndromes.

ALL begins when a bone marrow cell develops errors (mutations) in its DNA. DNA contains the instructions that tell a cell what to do. These mutations cause the cell to grow and divide uncontrollably, forming abnormal lymphoblasts instead of healthy blood cells. It's not clear why these mutations happen in most cases. While the exact cause is often unknown, certain factors can increase a person's risk of developing ALL. These risk factors include: Previous cancer treatment: People who have had chemotherapy or radiation therapy for other cancers may have a slightly higher risk. Certain genetic syndromes: Conditions like Down syndrome, Fanconi anemia, Bloom syndrome, and ataxia-telangiectasia are linked to an increased risk of ALL. Exposure to high levels of radiation: This could be from a nuclear accident, for example. Exposure to certain chemicals: For instance, high exposure to benzene, a chemical found in some industrial products, has been linked to an increased risk. It is important to understand that having a risk factor does not mean you will definitely get ALL, and many people with ALL have no known risk factors. ALL is generally not considered an inherited condition, meaning it does not typically run in families.

How it's diagnosed

Diagnosing acute lymphoblastic leukemia (ALL) typically involves a physical exam, blood tests to check cell counts, and a bone marrow biopsy to examine cells directly. Additional tests like a lumbar puncture or imaging scans may be performed to determine the extent of the cancer.

If your doctor suspects ALL based on your symptoms, they will likely recommend several tests: Physical exam: Your doctor will look for physical signs of leukemia, such as swollen lymph nodes, an enlarged spleen or liver, and pale skin. Blood tests: A complete blood count (CBC) measures the number of red blood cells, white blood cells, and platelets. In ALL, you will typically have too many immature white blood cells (lymphoblasts) and low counts of healthy red blood cells and platelets. Bone marrow exam: This is a key test. A small sample of liquid bone marrow (bone marrow aspiration) and a small piece of bone marrow tissue (bone marrow biopsy) are taken, usually from your hip bone. These samples are then examined under a microscope to look for leukemia cells. Lumbar puncture (spinal tap): This procedure collects a sample of cerebrospinal fluid (CSF) from around your spinal cord. It helps determine if the leukemia cells have spread to your brain and spinal cord. Imaging tests: X-rays, CT scans, MRI scans, or PET scans may be used to check for enlarged lymph nodes or other signs of cancer in different parts of your body. These tests help doctors understand how far the cancer has spread.

Treatment options

Treatment for acute lymphoblastic leukemia (ALL) usually involves several phases of chemotherapy, which uses strong drugs to kill cancer cells. Other options may include radiation therapy, targeted drug therapy, immunotherapy, or a stem cell transplant (bone marrow transplant), depending on the specific type of ALL and how it responds to initial treatment.

The primary treatment for ALL is chemotherapy, which is often given in several phases: Induction therapy: This intensive first phase aims to kill most of the leukemia cells in the blood and bone marrow, bringing the disease into remission (meaning no signs of cancer are found). This phase usually lasts a few weeks. Consolidation therapy: Also called intensification, this phase follows induction and aims to kill any remaining leukemia cells that might not have been destroyed. It helps prevent the cancer from returning. Maintenance therapy: This is a less intensive, longer-term phase, often lasting for years, to prevent a relapse. It involves lower doses of chemotherapy drugs. Other treatment options may include: Radiation therapy: This uses high-energy beams to kill cancer cells. It might be used to treat areas where leukemia has spread, such as the brain or spinal cord, or as preparation for a stem cell transplant. Stem cell transplant (bone marrow transplant): This procedure replaces diseased bone marrow with healthy blood-forming stem cells. It's often considered for people with high-risk ALL or those whose cancer has returned after initial treatment. The stem cells can come from a donor (allogeneic transplant) or, less commonly, from your own body (autologous transplant). Targeted drug therapy: These drugs focus on specific vulnerabilities present within cancer cells, often with fewer side effects than traditional chemotherapy. Immunotherapy: This treatment uses your body's own immune system to fight cancer. Some types of immunotherapy for ALL involve genetically modifying your own T-cells (a type of immune cell) to recognize and attack leukemia cells. Your care team will discuss the best treatment plan for your specific situation.

Recovery & outlook

The outlook for acute lymphoblastic leukemia (ALL) has significantly improved, especially for children, with many achieving long-term remission or a cure. Recovery involves ongoing monitoring and potential long-term side effects from treatment. The specific prognosis depends on factors like age, the type of ALL, and how well it responds to therapy.

The outlook for people with ALL varies greatly depending on several factors, including age at diagnosis, the specific genetic changes in the leukemia cells, and how quickly the cancer responds to treatment. Children generally have a better prognosis than adults, with a high percentage achieving remission and many being cured. For adults, the outlook is often more challenging, but advances in treatment continue to improve outcomes. After initial treatment, regular follow-up appointments, blood tests, and sometimes bone marrow exams are crucial to monitor for any signs of the cancer returning (relapse). Treatment for ALL can be intense and may lead to various side effects, both short-term and long-term. These can include fatigue, infections, heart problems, or issues with fertility. Your medical team will help manage these side effects and provide supportive care throughout your recovery. It's important to discuss any concerns about long-term health with your doctor.

When to see a doctor

You should see a doctor if you experience persistent or worsening symptoms that could indicate acute lymphoblastic leukemia (ALL), such as unexplained fatigue, frequent infections, easy bruising or bleeding, or bone pain. Early diagnosis is crucial for effective treatment and better outcomes.

While many symptoms of ALL can also be caused by less serious conditions, it's important to seek medical attention if they are persistent, severe, or unexplained. Do not delay seeing a doctor if you notice: Unusual or severe fatigue and weakness that doesn't improve with rest. Frequent or recurring infections or fevers without a clear cause. Easy bruising or bleeding, such as frequent nosebleeds, bleeding gums, or tiny red spots under the skin (petechiae). Persistent bone or joint pain that is not related to an injury. Swollen lymph nodes in your neck, armpits, or groin that don't go away. Unexplained weight loss or loss of appetite. These symptoms warrant a visit to your doctor for evaluation. They can perform initial tests to determine the cause of your symptoms and refer you to a specialist if needed.

Frequently asked questions

Is acute lymphoblastic leukemia (ALL) contagious?

No, acute lymphoblastic leukemia (ALL) is not contagious. It is a type of cancer caused by genetic changes within a person's own blood cells and cannot be spread from one person to another through contact or any other means.

Can ALL be prevented?

In most cases, acute lymphoblastic leukemia (ALL) cannot be prevented because its exact cause is unknown and it's not typically linked to lifestyle choices. While some risk factors exist, like certain genetic syndromes or previous cancer treatments, these are often not modifiable.

What is the difference between "acute" and "chronic" leukemia?

The main difference between "acute" and "chronic" leukemia lies in how quickly the disease progresses and the maturity of the cells involved. Acute leukemia, like ALL, involves immature blood cells that multiply rapidly and worsen quickly. Chronic leukemia involves more mature blood cells and tends to progress more slowly.

What are the common side effects of ALL treatment?

Common side effects of ALL treatment, especially chemotherapy, can include fatigue, nausea, vomiting, hair loss, mouth sores, increased risk of infection due to low white blood cell counts, and easy bruising or bleeding due to low platelet counts. Your care team will help manage these effects.

Does diet play a role in ALL treatment or recovery?

While diet cannot cure ALL, maintaining good nutrition is very important during treatment and recovery. Eating a balanced diet can help your body tolerate treatment side effects, maintain strength, and support your immune system. Your doctor or a dietitian can provide specific dietary recommendations.

How often do people with ALL relapse after treatment?

The risk of relapse for acute lymphoblastic leukemia (ALL) varies significantly depending on factors like age, the specific type of ALL, and the initial response to treatment. While many achieve long-term remission, some individuals, particularly adults or those with high-risk features, may experience a relapse, requiring further treatment.

Sources

• MedlinePlus — Acute Lymphoblastic Leukemia
• Mayo Clinic — Acute Lymphoblastic Leukemia
• Cochrane Library — Acute Lymphoblastic Leukemia